◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › CDNA

CareDx, Inc. (CDNA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-07-15

CareDx, Inc. (CDNA) operates in the Diagnostics & Research industry and is headquartered in Brisbane, United States with about 761 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, CDNA reported $380M in revenue and ($21M) in net income.

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Interactive charts & full statements → Open the CDNA valuation workbench →

CDNA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$380M$334M$280M$322M
Gross Profit$257M$224M$178M$210M
Operating Income (EBIT)($25M)($56M)($107M)($77M)
Net Income($21M)$52M($190M)($77M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CDNA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$118M$108M$100M$87M$85M
Gross Profit$84M$73M$69M$58M$56M
Operating Income (EBIT)$2M($6M)($0M)($11M)($8M)
Net Income$3M($4M)$2M($9M)($10M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CDNA Free Cash Flow History

CDNA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$413M$491M$467M$543M
Total Liabilities$110M$113M$206M$112M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CDNA viewer.

Other Companies in Diagnostics & Research

← CDLXAll stocksCDNL →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.